Zoe Y. Choi
Sar, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Long-term oral glucocerebrosidase activator reduces soluble α-synuclein oligomer accumulation in Parkinsonian LRRK2 mutant mouse brain.
Journal: NPJ Parkinson's disease
Published: July 22, 2025
Effects of Meditation and Yoga on Anxiety, Depression and Chronic Inflammation in Patients with Parkinson's Disease: A Randomized Clinical Trial.
Journal: Psychotherapy and psychosomatics
Published: October 04, 2024
Loss of mitochondrial Ca2+ response and CaMKII/ERK activation by LRRK2R1441G mutation correlate with impaired depolarization-induced mitophagy.
Journal: Cell communication and signaling : CCS
Published: July 22, 2024
In vivo overexpression of synaptogyrin-3 promotes striatal synaptic dopamine uptake in LRRK2R1441G mutant mouse model of Parkinson's disease.
Journal: Brain and behavior
Published: August 17, 2022
Transcriptional Regulation of the Synaptic Vesicle Protein Synaptogyrin-3 (SYNGR3) Gene: The Effects of NURR1 on Its Expression.
Journal: International journal of molecular sciences
Published: March 07, 2022
Long-term inhibition of mutant LRRK2 hyper-kinase activity reduced mouse brain α-synuclein oligomers without adverse effects.
Journal: NPJ Parkinson's disease
Published: February 24, 2022
LRRK2 mutant knock-in mouse models: therapeutic relevance in Parkinson's disease.
Journal: Translational neurodegeneration
Published: October 11, 2021
LRRK2, GBA and their interaction in the regulation of autophagy: implications on therapeutics in Parkinson's disease.
Journal: Translational neurodegeneration
Published: October 11, 2021
Aberrant mitochondrial morphology and function associated with impaired mitophagy and DNM1L-MAPK/ERK signaling are found in aged mutant Parkinsonian LRRK2R1441G mice.
Journal: Autophagy
Published: December 10, 2020
Showing 1-9 of 9
Last Updated: 09/26/2026